Trial
NCT01447758
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
LEO Pharma
Collaborators
—
Condition
Atopic Dermatitis
Intervention
LEO 29102
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-24